Back to HighTower Advisors, LLC HighTower Advisors, LLC

SGMOQSGMOQ
Showing 8 of 31 quarters

Position history for HighTower Advisors, LLCHighTower Advisors, LLC's holdings in SANGAMO THERAPEUTICS, INC

As of its Q1 2026 13F, HighTower Advisors held 706,481 shares of SGMOQ (Sangamo Therapeutics), worth $174,431. HighTower Advisors' 13F filings listed SGMOQ from Q4 2018 to Q1 2026, 30 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$647,000

Total Shares Change

-793,078

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.05
0
2026-Q1
Increased
706,481
+0.3%
$174,4310.0%$0.25
23
2025-Q4
Decreased
704,456
-5.3%
$295,8720.0%$0.42
0
2025-Q3
Decreased
744,106
-0.1%
$501,0810.0%$0.67
0
2025-Q2
Decreased
744,768
-2.1%
$403,1430.0%$0.54
0
2025-Q1
Increased
760,663
+0.5%
$498,8430.0%$0.66
24
2024-Q4
Decreased
756,823
-4.6%
$771,9590.0%$1.02
0
2024-Q3
Increased
793,078
+0.1%
$647,0000.0%$0.87
24

Other major holders of SGMOQ: WASATCH ADVISORS LP, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used